文献速递肿瘤 PET/CT

原发性子宫内膜肝样腺癌18F-FDG PET/CT罕见病例

A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2019-01-01

本文报道一例64岁女性阴道出血2个月、血清甲胎蛋白显著升高至3931 ng/mL的病例。宫腔镜分段诊刮提示子宫内膜腺癌,腹部增强CT未见肝脏病变排除原发性肝癌,分期18F-FDG PET/CT显示子宫内膜高代谢肿块,术后病理诊断为原发性子宫内膜肝样腺癌。

要点

  • 原发性子宫内膜肝样腺癌是罕见肿瘤,可表现为阴道出血伴血清甲胎蛋白显著升高。
  • 18F-FDG PET/CT可用于显示子宫内膜高代谢肿块并协助分期。
  • 腹部增强CT未见肝脏病变有助于排除原发性肝癌。

核心结论

  • 原发性子宫内膜肝样腺癌为罕见肿瘤,本例经术后病理确诊。

研究设计与样本

  • 单例病例报道:64岁女性,阴道出血2个月,血清甲胎蛋白3931 ng/mL。

主要发现

  • 宫腔镜分段诊刮提示子宫内膜腺癌。
  • 盆腔MRI显示仅子宫内膜肿块。
  • 腹部增强CT未见肝脏病变,排除原发性肝癌。
  • 分期18F-FDG PET/CT显示子宫内膜高代谢肿块。
  • 行全子宫切除加双侧附件切除及区域淋巴结清扫,术后病理诊断为原发性子宫内膜肝样腺癌。

临床怎么用

  • 对阴道出血伴甲胎蛋白显著升高的患者,应将子宫内膜肝样腺癌纳入鉴别诊断。
  • 18F-FDG PET/CT可用于显示子宫内膜高代谢肿块并协助分期。
  • 腹部增强CT未见肝脏病变有助于排除原发性肝癌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary endometrial hepatoid adenocarcinoma is a rare tumor. We present a case of a 64-year-old woman with vaginal bleeding for 2 months and a markedly elevated serum α-fetoprotein of 3931 ng/mL. Hysteroscopic segmental curettage revealed endometrial adenocarcinoma. A pelvic MRI was performed for local tumor invasion, which showed only endometrial mass. An abdominal enhanced CT showed no liver lesion, which excluded primary hepatic carcinoma. Staging F-FDG PET/CT demonstrated a hypermetabolic mass in the endometrium. A total hysterectomy with bilateral salpingo-oophorectomy and regional lymphadenectomy were performed. Postoperatively, the mass was diagnosed as primary endometrial hepatoid adenocarcinoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yin H, Hu Y, Xiu Y, et al. A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT. Clin Nucl Med. 2019. PMID: 30985410. doi:10.1097/RLU.0000000000002538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。